Skip to content

Heart2Heart: Implementation of a peer support program for people with heart disease

Heart2Heart: Implementation of a peer support program for people with heart disease: a community-based, investigator-blinded randomised controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000386538
Acronym
Heart2Heart
Enrollment
15
Registered
2024-04-03
Start date
2024-06-02
Completion date
2025-12-31
Last updated
2024-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Heart2Heart is a community-based randomised controlled trial with 12 months follow-up. The aim of the study is to determine whether implementation of a digital peer support program for people living with CHD is effective in improving social connectedness, clinical and patient-reported outcomes and experience measures. The intervention group will have access to a 6-month intervention that enables peer support via an interactive mobile application, which includes online discussion groups, access to resources and facilitated conversations with health professionals. If effective, the digital peer support intervention has the potential to increase social connectedness and empower people to self-manage and support others through sharing lived experience and learning.

Interventions

The intervention group will have access to a 6-month intervention that enables peer support via an interactive mobile application (app). Participants will be able to access the app down download from their personal mobile device. The intervention includes online peer discussion groups via discussion board (e.g., exercise and diet) in the app, access to digital educational resources (web-based information such as text, images, and videos), and facilitated conversations with health professionals (

The intervention group will have access to a 6-month intervention that enables peer support via an interactive mobile application (app). Participants will be able to access the app down download from their personal mobile device. The intervention includes online peer discussion groups via discussion board (e.g., exercise and diet) in the app, access to digital educational resources (web-based information such as text, images, and videos), and facilitated conversations with health professionals (e.g., cardiac nurse, physiotherapist, dietician etc.). All participants will have access to all discussions and groups within the CVD community. Health professionals will be joining into the discussion groups periodically, post educational resources, as well as facilitate conversations with participants. The facilitated discussions will be online and likely less than a few minutes in duration on each occasion, however duration will vary and will be generic in nature with anything substantial in medical information requirements, the participants will be encouraged to discuss more fully with their general practitioners or other personal health provider. There will be no specific number of times per week required, however, participant will be encouraged to use the app as many times as they want. Adherence and engagement with the app will be monitored through analytic report provided by the app company (e.g., user session time, login tracker, engagement etc.).

Sponsors

The University of Sydney
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Educational / counselling / training
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

(i) aged at least 18 years; (ii) have confirmed diagnosis of heart disease; and iii) own an active mobile device.

Exclusion criteria

(i) major neurocognitive diagnoses; (ii) not willing/able to give informed consent; and (iii) are unable to read or speak English; and (iv) severe heart failure (NYHA class III or IV).

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026